Market closed
Ingevity/NGVT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ingevity
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.
Ticker
NGVT
Sector
Trading on
NYSE
Industry
Chemicals
Headquarters
Employees
1,700
Website
Ingevity Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$11.90
EPS
1.67
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
1.67
52-week high
$56.30
52-week low
$30.90
Average daily volume
341K
Financial strength
Current ratio
1.917
Quick ratio
0.897
Long term debt to equity
506.636
Total debt to equity
549.298
Interest coverage (TTM)
2.42%
Management effectiveness
Return on assets (TTM)
5.63%
Return on equity (TTM)
-86.35%
Valuation
Price to revenue (TTM)
0.74
Price to book
4.03
Price to tangible book (TTM)
-6.1
Price to free cash flow (TTM)
15.999
Growth
Revenue change (TTM)
-11.01%
Earnings per share change (TTM)
-352.01%
3-year revenue growth (CAGR)
5.04%
3-year earnings per share growth (CAGR)
32.59%
What the Analysts think about Ingevity
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Ingevity stock.
Ingevity Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Ingevity Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Ingevity News
AllArticlesVideos
Ingevity updates third-quarter 2024 earnings release and webcast dates
Business Wire·1 week ago
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
Benzinga·3 weeks ago
Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Ingevity stock?
Ingevity (NGVT) has a market cap of $1.1B as of October 24, 2024.
What is the P/E ratio for Ingevity stock?
The price to earnings (P/E) ratio for Ingevity (NGVT) stock is 0 as of October 24, 2024.
Does Ingevity stock pay dividends?
No, Ingevity (NGVT) stock does not pay dividends to its shareholders as of October 24, 2024.
When is the next Ingevity dividend payment date?
Ingevity (NGVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Ingevity?
Ingevity (NGVT) has a beta rating of 1.67. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.